SEI Investments’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
SEI Investments's PCVX Position: Q3 2026 in Review
SEI Investments increased its Vaxcyte (PCVX) stake by 31% in Q3 2026, buying an estimated $602K and bringing the position to 43,841 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.
SEI Investments first reported a position in PCVX in Q4 2022 and has held it in 16 quarters since. The position peaked at $20.5M in Q3 2024. 202 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- SEI Investments held 43,841 shares of Vaxcyte worth $2.49M as of Q3 2026.
- SEI Investments bought 10,325 Vaxcyte shares in Q3 2026, an estimated $602K.
- Vaxcyte made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #1848 holding.
- SEI Investments first reported a position in Vaxcyte in Q4 2022 and has held it in 16 quarters since.
- SEI Investments's Vaxcyte position peaked at $20.5M in Q3 2024.
- 202 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.